Patents by Inventor Verena Baldinger

Verena Baldinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Complex-bound inhibitors of metabolic enzymes capable of being activated, useful as molecular markers for diagnostic and therapy monitoring purposes
    Patent number: 6051390
    Abstract: This invention relates to the use of an inhibitor of an activatable metabolic enzyme, which inhibitor is bound to a high molecular weight carrier, as a molecular marker for determining the activation of this enzyme for the diagnosis of the enzyme. The invention relates in particular to the use of a thrombin inhibitor, which is bound to a high molecular weight carrier, as a molecular marker for determining clotting activation in clotting diagnosis and therapy monitoring. The invention preferably relates to the use of dextran-hirudin or PEG-coupled hirudin as a molecular marker for clotting diagnosis and therapy monitoring.
    Type: Grant
    Filed: May 26, 1998
    Date of Patent: April 18, 2000
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V., Berlin
    Inventors: Gotz Nowak, Elke Bucha, Verena Baldinger
  • Sulfonamide derivatives and drugs obtained therefrom
    Patent number: 4999345
    Abstract: Sulfonamide derivatives of the formula I ##STR1## where R.sup.1 is a C.sub.1 -C.sub.4 -alkyl or phenyl group which may be substituted by halogen, trifluoromethyl or C.sub.1 -C.sub.4 -alkyl, R.sup.2 is hydrogen or C.sub.1 -C.sub.4 -alkyl, A is a group CHOR.sup.3 C.dbd.O, C.dbd.S or C.dbd.N--OR.sup.4, R.sup.3 is hydrogen, C.sub.1 -C.sub.4 -alkyl phenyl, benzyl or C.sub.1 -C.sub.4 -acyl, R.sup.4 is hydrogen or methyl, B may be methylene or ethylene in the m or p position or, of A is not carbonyl, may be methyleneoxy, the oxygen atom being bonded to the aromatic, and E is a carboxyl, phosphonic acid or sulfo radical, their physiologically acceptable salts, esters with C.sub.1 -C.sub.4 -alcohols or amides or the tetrazol-5-yl radical, their preparation and their use as drugs.
    Type: Grant
    Filed: May 26, 1989
    Date of Patent: March 12, 1991
    Assignee: BASF Aktiengesellschaft
    Inventors: Bernhard Schmied, Hand D. Lehmann, Verena Baldinger, Klaus Ruebsamen
  • Phenylacetonitriles which are substituted by basic groups, their preparation and drugs containing these substances
    Patent number: 4968717
    Abstract: Compounds of the formula ##STR1## where R.sup.1 to R.sup.7, m, n and p have the meanings stated in the description, and certain derivatives which are p-substituted in the left-hand phenyl ring, are useful for the treatment of disorders.
    Type: Grant
    Filed: May 12, 1989
    Date of Patent: November 6, 1990
    Assignee: BASF Aktiengesellschaft
    Inventors: Liliane Unger, Manfred Raschack, Verena Baldinger, Ferdinand Dengel, Oskar Ehrmann, Hans J. Treiber, Werner Seitz
  • Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
    Patent number: 4940780
    Abstract: Basically substituted phenylacetonitriles ##STR1## where R.sup.1 to R.sup.6 and n have the meanings stated in the description, and their preparation are described. The compounds are useful for the treatment of disorders.
    Type: Grant
    Filed: December 10, 1987
    Date of Patent: July 10, 1990
    Assignee: BASF Aktiengesellschaft
    Inventors: Werner Seitz, Liliane Unger, Manfred Raschack, Verena Baldinger, Klaus Ruebsmen, Josef Gries
  • (S)-emopamil for the treatment of migraine
    Patent number: 4914125
    Abstract: The use of (S)-emopamil and the salts thereof for the treatment of migraine is described.
    Type: Grant
    Filed: July 6, 1989
    Date of Patent: April 3, 1990
    Assignee: Knoll AG
    Inventors: Verena Baldinger, Liliane Unger, Laszlo Szabo
  • Phenylacetaldehydes substituted by basic groups, their preparation and drugs containing these compounds
    Patent number: 4723039
    Abstract: Phenylacetaldehydes which are substituted by basic groups, of the formula ##STR1## where R.sup.1 to R.sup.8, m and n have the meanings stated in the description, and their preparation are described. The substances are useful for the treatment of disorders.
    Type: Grant
    Filed: December 4, 1986
    Date of Patent: February 2, 1988
    Assignee: BASF Aktiengesellschaft
    Inventors: Werner Seitz, Verena Baldinger, Josef Gries, Dieter Lenke, Manfred Raschack, Klaus Ruebsamen